Ontaxel Injection 6 mg/ml contains Paclitaxel, a potent anticancer chemotherapy agent classified as a taxane derivative. Paclitaxel works by stabilizing microtubules in cancer cells, preventing them from dividing and proliferating, which ultimately leads to cell death. This mechanism makes Ontaxel highly effective in treating a variety of solid tumors.

Paclitaxel has been extensively used in oncology for its efficacy against several cancers, including breast cancer, ovarian cancer, lung cancer, and certain types of head and neck cancers. The injectable formulation allows for precise dosing and administration under controlled medical supervision, ensuring maximum therapeutic effect with monitored safety.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Ontaxel Injection 6 mg/ml is indicated for the treatment of:

• Breast cancer: Early-stage, locally advanced, or metastatic breast cancer.

• Ovarian cancer: First-line therapy for advanced ovarian cancer or after relapse.

• Non-small cell lung cancer (NSCLC): As part of combination chemotherapy regimens.

• Other solid tumors: Including head and neck cancers, and esophageal cancer, as advised by an oncologist.

It is typically used under professional supervision in oncology settings, often in combination with other chemotherapy agents for improved outcomes.

Key Benefits

• Potent anticancer activity: Inhibits cell division and tumor growth effectively.

• Versatile applications: Treats a wide range of solid tumors.

• Combination therapy compatible: Often used with other chemotherapeutic drugs or targeted therapies to enhance efficacy.

• Clinical efficacy: Demonstrated improvement in survival rates and tumor response in multiple cancers.

• Controlled administration: Injectable form allows precise dosing under medical supervision, reducing risks of improper intake.

Ontaxel Injection is a cornerstone in modern oncology for patients requiring advanced cancer management.

Dosage and Administration

• The dose and schedule of Ontaxel Injection vary depending on the type of cancer, patient weight, and treatment protocol.

• Intravenous infusion only: Administered over 3–24 hours using a controlled IV infusion, typically with pre-medications to reduce hypersensitivity reactions.

• Premedication: Corticosteroids, antihistamines, and H2 blockers are often given to minimize allergic reactions.

• Dose adjustment may be necessary in patients with liver impairment, low blood counts, or prior chemotherapy toxicity.

• Close monitoring of blood counts, liver function, and overall health is essential during therapy.

Administration must be performed by trained oncology healthcare professionals in a hospital or infusion center.

Precautions

• Monitor patients for hypersensitivity reactions, especially during the first infusion.

• Use with caution in individuals with impaired liver function, pre-existing neuropathy, or low blood cell counts.

• Inform the healthcare provider of all medications to prevent interactions, particularly other cytotoxic drugs.

• Not suitable for pregnant or breastfeeding women, unless specifically advised by an oncologist.

• Regular monitoring of blood counts, liver enzymes, and neurological status is recommended during treatment.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include:

• Hair loss (alopecia)

• Nausea and vomiting

• Fatigue and weakness

• Peripheral neuropathy (numbness or tingling in hands and feet)

• Low blood counts (neutropenia, anemia, thrombocytopenia)

Rare but serious side effects may include severe allergic reactions, heart rhythm abnormalities, liver toxicity, or severe infections. Immediate medical attention is required if severe reactions occur.

Storage Instructions

• Store at 2–8°C (refrigerated) and protect from light.

• Do not freeze the injection.

• Keep out of reach of children.

• Use immediately after preparation or follow medical guidelines for storage.

Ontaxel Injection 6 mg/ml (Paclitaxel) is a powerful chemotherapy agent for the treatment of various solid tumors. When administered under medical supervision, it provides effective tumor suppression, improves patient outcomes, and remains a key component of modern cancer therapy.